Acura Pharmaceuticals, Inc. (ACUR)

Acura Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	0	0	1.56	3.57	2.66	0.41
Revenue Growth (YoY)	-	-	-56.22%	34.36%	548.05%	-86.18%
Cost of Revenue	0	0	1.21	0	0	0
Gross Profit	0	0	0.35	3.57	2.66	0.41
Selling, General & Admin	0	0	1.25	2.55	1.88	2.57
Research & Development	0	0	1.52	1.78	1.51	1.76
Other Operating Expenses	0	0	0	0	0	0.3
Operating Expenses	0	0	2.78	4.33	3.38	4.33
Operating Income	0	0	-1.21	-0.76	-0.73	-3.92
Interest Income	0	0	0	0	0.01	0.17
Interest Expense	0	0	0.2	0.45	0.45	0.22
Other Expense / Income	-	-	-0.53	0	2.61	-0.59
Pretax Income	0	0	-0.88	-1.21	-3.77	-3.84
Income Tax	0	0	0.2	0.45	0.18	0.47
Net Income	0	0	-1.08	-1.66	-3.95	-3.84
Shares Outstanding (Basic)	-	-	57	32	27	21
Shares Outstanding (Diluted)	-	-	57	32	27	21
Shares Change	-	-	75.75%	20.96%	26.36%	32.97%
EPS (Basic)	-	-	-0.02	-0.05	-0.15	-0.18
EPS (Diluted)	-	-	-0.02	-0.05	-0.15	-0.18
Free Cash Flow	0	0	-0.74	-0.72	-0.62	-3.91
Free Cash Flow Per Share	-	-	-0.01	-0.02	-0.02	-0.18
Gross Margin	-	-	22.52%	99.95%	99.94%	99.57%
Operating Margin	-	-	-77.67%	-21.23%	-27.29%	-954.88%
Profit Margin	-	-	-69.03%	-46.44%	-148.66%	-937.07%
Free Cash Flow Margin	-	-	-47.47%	-20.14%	-23.26%	-953.17%
EBITDA	0	0	-1.21	-0.63	-0.73	-3.62
EBITDA Margin	-	-	-77.67%	-17.73%	-27.29%	-882.68%
Depreciation & Amortization	0	0	0.09	0.13	0.27	0.28
EBIT	-	-	-1.3	-0.76	-1	-3.9
EBIT Margin	-	-	-83.43%	-21.23%	-37.56%	-950.98%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.